Redmile Group, LLC, 10% Owner at XERIS PHARMACEUTICALS INC (XERS), bought 2,412,642 shares at $15.00 ($10.0M) on 2018-06-25, disclosed to the SEC on 2018-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,745,974 | $0 | 0.0% |
| 2 | $15.00 | 666,668 | $10.0M | 100.0% |
| Total | $4.14 avg | 2,412,642 | $10.0M | 100% |
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |